Patients' Perspective, Quality of Life and Treatment Goals in Hailey-Hailey Disease: lessons learned from the German National Registry

J Eur Acad Dermatol Venereol
20 October 2023
https://pubmed.ncbi.nlm.nih.gov/37863661/

Background: Hailey-Hailey disease (HHD) remains a difficult-to-treat dermatosis and little is known about the patient's perception of the disease activity, the treatment success, and its impact on quality-of-life (QoL).

Linda Bluestein, MD - LDN Radio Show August 2023 (LDN; low dose naltrexone)

Is low-dose naltrexone effective in chronic pain management?

J Fam Pract
September 2023
https://pubmed.ncbi.nlm.nih.gov/37729143/

Masoud Rashidi, PharmD - LDN, ULDN for Pain - 2022 Conference (LDN; low dose naltrexone)

Neel Mehta, MD - An Alternative to Opioids - 2022 Conference (LDN; low dose naltrexone)

Christine Lee, PharmD - Migraines - 2022 Conference (LDN; low dose naltrexone)

Kristen Cardamone, DO, FABPMR - LDN in Pain - 2022 Conference (LDN; low dose naltrexone)

Nellmarie Bodenstein, GP - Clinical use of LDN in South Africa - 2022 Conference (LDN, low dose naltrexone)